| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b67f74ebd248af69cdcea2a0d87bddf2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_46b07b5bf4bd319c1185b9744edf769f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_51b1a12d305b7e1f443b56eb61e79d4f |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M1-287
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-718
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-724 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M1-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-724
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N1-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-718
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-715 |
| filingDate |
2006-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d53e408d888c152ac8490ae69fde2eea
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3384473c9c083302ab5a0f7188da7c43
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8df9baa5daf90c2b77114a0447b96b70 |
| publicationDate |
2006-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2006128658-A1 |
| titleOfInvention |
Biocompatible dialysis fluids containing icodextrins |
| abstract |
Icodextrin-based solutions and methods of making same that can be used during medical therapy, such as dialysis therapy are provided. The icodextrin-based solution at least includes a first solution containing icodextrin at a pH ranging from about 1.5 to about 5.0 and a buffer solution at a pH ranging from about 7.0 to about 12.0 that are so constructed and arranged allowing the icodextrin-based solution to be mixed prior to infusion into a patient. The icodextrin-based solutions of the present invention can be made at physiologic pH and with minimal glucose degradation products. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10010563-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11617764-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006226080-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11020420-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11020520-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018179974-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8975240-B2 |
| priorityDate |
2002-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |